The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
N-desethyl isotonitazene detected in polydrug users admitted to hospital in Birmingham, United Kingdom
Abstract
Introduction Nitazenes are potent synthetic opioids and N-desethyl isotonitazene, a metabolite of isotonitazene, has emerged as a drug in its own right.Methods This is an observational case series of patients with suspected or declared substance use who were admitted to hospitals in the Sandwell and West Birmingham National Health Service Trust between July and October 2023. All patients were found on toxicological screening to have been exposed to N-desethyl isotonitazene.Results Twenty presentations involving 19 patients who tested positive for N-desethyl isotonitazene were included in the study. In 19 presentations, multiple substances were detected on toxicological screening. The number of patients testing positive for other substances were: 19 for cocaine and its main metabolite benzoylecgonine, 13 for morphine, 11 for the heroin-specific metabolite 6-monoacetylmorphine, ten for xylazine, eight for gabapentinoids (pregabalin and/or gabapentin), seven for methadone and/or the metabolite, 2-ethylidene-1, 5-dimethyl-3, 3-diphenylpyrrolidine, six for benzodiazepines and five for the synthetic cannabinoid MDMB-4en-PINACA. Only one patient had no other substances detected apart from N-desethyl isotonitazene. This patient presented with coma, miosis, bradypnoea and hypercapnia and responded to naloxone. In this cohort, the median concentration of N-desethyl isotonitazene was 1.53 µg/L (n = 14; range 0.59–5.48) in whole blood and 27.75 µg/L (n = 16; range 0.51–91.53) in urine.Discussion The majority of the patients in this cohort presented with features typical of an opioid overdose, which is unsurprising as they were all experienced users of diamorphine. Although these features are also consistent with the known effects of N-desethyl isotonitazene, in only one case is it possible to attribute the patient’s features to N-desethyl isotonitazene toxicity alone.Conclusions This case series highlights the need for toxicovigilance in the illicit drug market as patterns of substance misuse evolve and novel psychoactive substances continue to emerge.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Polysubstance use is a common complicating factor, as nitazenes are rarely encountered in isolation.”
From Nitazenes: The Emergence of a Potent Synthetic Opioid Threat (2025) · cites this paper as [41]
In the citing paper
“They are frequently mixed with other potent substances, including fentanyl, heroin, methamphetamine, benzodiazepines, and xylazine.”
From Nitazenes: The Emergence of a Potent Synthetic Opioid Threat (2025) · cites this paper as [41]
In the citing paper
“This complex mixture complicates toxicological interpretation and clinical management, especially when users are unaware of nitazene exposure, thereby increasing the risk of severe overdose [41,60].”
From Nitazenes: The Emergence of a Potent Synthetic Opioid Threat (2025) · cites this paper as [41]
Citations
Cites
Ruiz-Colón, K., Chavez-Arias, C., Díaz-Alcalá, J. E., & Martínez, M. A. (2014) · Forensic Science International · doi:10.1016/j.forsciint.2014.03.015 · Cited by 262
Johnson, J., Pizzicato, L., Johnson, C., & Viner, K. (2021) · Injury Prevention · doi:10.1136/injuryprev-2020-043968 · Cited by 183
Isotonitazene Quantitation and Metabolite Discovery in Authentic Forensic Casework
Krotulski, A. J., Papsun, D. M., Kacinko, S. L., & Logan, B. K. (2020) · Journal of Analytical Toxicology · doi:10.1093/jat/bkaa016 · Cited by 146
Xylazine (veterinary sedative) use in Puerto Rico
Torruella, R. A. (2011) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/1747-597x-6-7 · Cited by 119
Walton, S. E., Krotulski, A. J., & Logan, B. K. (2022) · Journal of Analytical Toxicology · doi:10.1093/jat/bkab117 · Cited by 92
Opioid overdoses involving xylazine in emergency department patients: a multicenter study
Love, J. S., Levine, M. S., Aldy, K., Brent, J. A., Krotulski, A. J., Logan, B. K., Vargas-Torres, C. C., Walton, S. E., Amaducci, A. M., Calello, D. P., et al. (2023) · Clinical Toxicology · doi:10.1080/15563650.2022.2159427 · Cited by 92
Montanari, E., Madeo, G., Pichini, S., Busardò, F. P., & Carlier, J. (2022) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000970 · Cited by 89
Old Drugs and New Challenges: A Narrative Review of Nitazenes
Pergolizzi Jr, J., Raffa, R., LeQuang, J. A. K., Breve, F., & Varrassi, G. (2023) · Cureus · doi:10.7759/cureus.40736 · Cited by 81
Xylazine poisoning: a systematic review
Ball, N. S., Knable, B. M., Relich, T. A., Smathers, A. N., Gionfriddo, M. R., Nemecek, B. D., Montepara, C. A., Guarascio, A. J., Covvey, J. R., & Zimmerman, D. E. (2022) · Clinical Toxicology · doi:10.1080/15563650.2022.2063135 · Cited by 75
Mu-Opioid Receptor Selective Superagonists Produce Prolonged Respiratory Depression
Malcolm, N. J., Palkovic, B., Sprague, D. J., Calkins, M. M., Lanham, J. K., Halberstadt, A. L., Stucke, A. G., & McCorvy, J. D. (2023) · iScience · doi:10.1016/j.isci.2023.107121 · Cited by 53
Cited by
De Vrieze, L. M., Walton, S. E., Pottie, E., Papsun, D., Logan, B. K., Krotulski, A. J., Stove, C. P., & Vandeputte, M. M. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03774-7 · Cited by 58
Vandeputte, M. M., & Stove, C. P. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110470 · Cited by 36
Nitazenes: review of comparative pharmacology and antagonist action
Stangeland, M., Dale, O., & Skulberg, A. K. (2025) · Clinical Toxicology · doi:10.1080/15563650.2025.2504133 · Cited by 34
“Calello et al. [25] and Amaducci et al. [42,43] reported reversal doses ranging from 0.08 mg to 2.00 mg, whereas Pucci et al. [30] concluded that the pre-hospital median dose of naloxone 0.80 mg (range: 0.40–2.00 mg) was consistent with typical doses required to reverse acute poisoning from potent…”
InfluentialNitazene test strips: a laboratory evaluation
De Vrieze, L. M., Stove, C. P., & Vandeputte, M. M. (2024) · Harm Reduction Journal · doi:10.1186/s12954-024-01078-8 · Cited by 34
“A recent report from the United Kingdom exemplifies this danger, as 19 drug users were hospitalized with severe opioid intoxication, each unaware that they had taken a nitazene opioid [17].”
BackgroundAmeline, A., Gheddar, L., Pichini, S., Stove, C., Aknouche, F., Maruejouls, C., Raul, J.-S., & Kintz, P. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.119764 · Cited by 26
Metadata
- Authors
- Pucci, M., Singh Jutley, G., Looms, J., & Ford, L.
- Affiliations
- Sandwell & West Birmingham Hospitals NHS Trust (GB)
- West Midlands Poisons Unit, Sandwell and West Birmingham NHS Trust, Birmingham, UK
- Corresponding author
- Pucci, Mark
- Venue
- Clinical Toxicology
- Publisher
- Informa UK Limited
- Published
- 2024-01-02
- Volume
- 62
- Issue
- 1
- Pages
- 19-25
- ISSN
- 0009-9309 (ISSN-L)
- 1556-3650
- 1556-9519
- OpenAlex
- W4391809867
- Cited by
- 37
- References
- 14
- Citations by year
- 2026: 7 · 2025: 22 · 2024: 8
- FWCI
- 8.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
- Keywords
- isotonitazene, nitazenes, synthetic opioids, polydrug use, opioid overdose, toxicity screening, cocaine, xylazine, gabapentinoids, MDMB-4en-PINACA, benzodiazepines, morphine metabolites, toxicovigilance, new psychoactive substances, hospitalization
- MeSH terms
- Analgesics, Opioid, Benzimidazoles, Heroin, Hospitals, Humans, State Medicine, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: N-desethyl isotonitazene detected in polydrug users admitted to hospital in Birmingham, United Kingdom. https://app.cochat.ai/papers/10.1080/15563650.2024.2309321
- The paper
- Pucci, M., Singh Jutley, G., Looms, J., & Ford, L. (2024). N-desethyl isotonitazene detected in polydrug users admitted to hospital in Birmingham, United Kingdom. Clinical Toxicology. https://doi.org/10.1080/15563650.2024.2309321
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.